Development of a Clinical Prediction Model to Predict Malignant Transformation of Sinonasal Inverted Papilloma Based on Hematological Indices and Clinical Features
- PMID: 39917629
- PMCID: PMC11800132
- DOI: 10.1002/lio2.70075
Development of a Clinical Prediction Model to Predict Malignant Transformation of Sinonasal Inverted Papilloma Based on Hematological Indices and Clinical Features
Abstract
Objective: Sinonasal inverted papilloma (SNIP) has a risk of malignant transformation into SNIP with squamous cell carcinoma (SNIP-SCC). Early detection of SNIP-SCC is crucial for patient outcomes. This study aimed to evaluate the utility of tumor-related hematological indices in the early diagnosis of SNIP-SCC and to develop a nomogram incorporating imaging and clinical features.
Methods: This study included 159 patients with SNIP with (n = 34) or without (n = 125) SCC. Univariate and multivariate logistic regression analyses were employed to identify independent risk factors and develop nomogram. The diagnostic model was evaluated using receiver operating characteristics (ROC), standard, clinical decision, and clinical impact curves.
Results: Elevated serum cytokeratin fragment antigen 21-1 (CYFRA 21-1), the loss of convoluted cerebriform pattern, bone destruction, headache/facial pain, and epistaxis/blood-tinged mucus were identified as independent risk factors for SNIP-SCC. The optimal cut-off value for serum CYFRA 21-1 was 3.51 ng/mL, with the nomogram area under the ROC curve of 0.966 based on the above indicators.
Conclusion: The findings suggest that CYFRA 21-1 is a promising diagnostic marker for SNIP-SCC. The nomogram incorporating serum CYFRA 21-1, imaging features, and clinical factors demonstrates strong clinical utility and can be a reference tool for clinical decision-making.
Keywords: cytokeratin fragment antigen 21‐1; malignant transformation; nomogram; sinonasal inverted papilloma.
© 2025 The Author(s). Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


References
-
- Melroy C. T. and Senior B. A., “Benign Sinonasal Neoplasms: A Focus on Inverting Papilloma,” Otolaryngologic Clinics of North America 39, no. 3 (2006): 601–617. - PubMed
-
- Zhang L., Fang G., Yu W., Yang B., Wang C., and Zhang L., “Prediction of Malignant Sinonasal Inverted Papilloma Transformation by Preoperative Computed Tomography and Magnetic Resonance Imaging,” Rhinology 58, no. 3 (2020): 248–256. - PubMed
-
- Mirza S., Bradley P. J., Acharya A., Stacey M., and Jones N. S., “Sinonasal Inverted Papillomas: Recurrence, and Synchronous and Metachronous Malignancy,” Journal of Laryngology and Otology 121, no. 9 (2007): 857–864. - PubMed
-
- Yan C. H., Tong C. C. L., Penta M., et al., “Imaging Predictors for Malignant Transformation of Inverted Papilloma,” Laryngoscope 129, no. 4 (2019): 777–782. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials